In addition, the discovery of mechanisms underlying leukemia pathogenesis has highlighted that many of them are involved in ABCG2 regulation, so identifying potential therapeutic targets to indirectly inhibit ABCG2 expression and offering a new perspective to counteract ABCG2-mediated drug resistance is able to modify leukemia cell biology. The gene discussed is ABCG2; the disease is leukemia.